학술논문
Reply to "Switch from ustekinumab to guselkumab in patients with psoriasis in real clinical practice using the "minimal disease activity" parameter".
Document Type
Article
Author
Source
Subject
*PSORIASIS
*TYPE 2 diabetes
*
Language
ISSN
1396-0296